Key Takeaways

  • Zeiss announced successful early clinical implantations of the AT LUCIA toric 721P, a new toric IOL designed to treat cataracts while correcting astigmatism
  • Early-access clinical trial surgeons across six European countries reported positive initial experiences
  • The CE-marked lens is expected to launch in select European markets later in 2026

Zeiss announced the successful early clinical implantations of the Zeiss AT LUCIA toric 721P IOL, a new toric lens designed to treat cataracts while simultaneously correcting astigmatism. The company is currently conducting an early-access clinical trial involving a select group of cataract surgeons across the Czech Republic, Germany, Italy, Spain, Sweden and the United Kingdom.

According to Zeiss, surgeons participating in the trial have reported positive early impressions of the lens, citing its precision, rotational stability and surgical handling characteristics. 

"The overwhelmingly positive feedback we've received from surgeons strongly validates our optics leadership in the IOL market," said Frank Seitzinger, Head of Business Sector Surgery Anterior Segment at Zeiss Medical Technology. "The Zeiss AT LUCIA toric 721P raises the bar for precision, stability, and ultimately positive surgical outcomes. This is a new era for IOL technology and Zeiss is at the forefront."

The company plans to showcase the AT LUCIA toric 721P for the first time at the International Congress of German Ophthalmic Surgery (DOC) in Nuremberg, Germany, taking place June 18-20, 2026. The lens has received CE marking and is expected to launch commercially in select European countries later this year.

Among the first surgeons to implant the lens was Andrea Janeková, PhD, FEBO, FEBOS-CR, Head of the Center for Cataract, Refractive and Vitreoretinal Surgery at Eye Center Prague in the Czech Republic.

"Being the first surgeon worldwide to implant the Zeiss AT LUCIA toric 721P was a privilege," Dr. Janeková said. "The lens combines precision, stability and excellent surgical handling. And in modern cataract surgery, precision matters more than ever. Based on my first experience, the Zeiss AT LUCIA toric 721P has all the ingredients of a true game changer for refractive outcomes."

Additional information on the clinical trial program and surgeon experiences is available from Zeiss.